Peripartum cardiomyopathy. Presentation of a case

Authors

  • José Miguel Vera Pérez Hospital Clínico Quirúrgico Docente Celia Sánchez Manduley. Manzanillo. Granma
  • Leandro Ortíz Hernández Hospital Clínico Quirúrgico Docente Celia Sánchez Manduley. Manzanillo. Granma
  • Odelinda Piñeiro Mora Hospital Clínico Quirúrgico Docente Celia Sánchez Manduley. Manzanillo. Granma

Keywords:

cardiomyopathies, left ventricular dysfunction, heart failure, third pregnancy trimester.

Abstract

Introduction: peripartum cardiomyopathy is a potentially very serious disease that presents as left ventricular systolic dysfunction with symptoms and signs of heart failure that appears in the last month of pregnancy or within the first 6 months postpartum, in the absence of previous heart disease.
Case presentation
: 26-year-old patient with black skin color and health history: obstetric history of 4 pregnancies, 2 abortions and 2 deliveries by caesarean section due to preeclampsia and after 26 weeks presented arterial hypertension, treated with 3 tablets daily of methyldopa, control was achieved. At 8 hours after the elective cesarean section, he presented symptoms of systolic heart failure according to the criteria of postpartum cardiomyopathy, the echocardiogram reported globally depressed left ventricular contractility with ejection fraction between 26 and 27 %, required intensive surveillance, intensive treatment and work multidisciplinary, applying the protocolized treatment with favorable evolution.
Conclusions
: peripartum cardiomyopathy was presented as acute pulmonary edema that progressed to cardiogenic shock; as an etiological theory, the autoimmune response of the disordered mother to fetal antigens or cardiotoxic effects of prolactin, factors associated with preeclampsia and skin color. This is a clinical entity with a very low incidence that occurs in the form of heart failure. Echocardiography is important, but the anamnesis and a careful physical examination are the best weapons that clinicians, obstetricians and intensivists have to reach a correct diagnosis.

Downloads

Download data is not yet available.

References

1. Chun EJ, Choi SI, Jin KN, Kwag HJ, Kim YJ, Choi BW, et al. Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. Radiographics [Internet]. 2010 Sep [citado 16 Abr 2017]; 30(5):1309-28. Disponible en: https://pubs.rsna.org/doi/full/10.1148/rg.305095074.

2. Hanneman K, Nguyen ET, Crean AM. Hypertrophic Cardiomyopathy Complicated by Pulmonary Edema in the Postpartum Period. Case Rep Radiol [Internet]. 2013 [citado 16 Abr 2017]; 3: 802352. Disponible en: https://www.hindawi.com/journals/crira/2013/802352/.

3. Anderson JL, Horne BD. Birth in the genetics of peripartum cardiomyopathy. Circulation [Internet]. 2010 [citado 16 Abr 2017]; 121(20):2157–9. Disponible en: http://circ.ahajournals.org/content/121/20/2157.

4. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol [Internet]. 2010 Feb [citado 16 Abr 2017]; 55(7):654-9. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109709039230?via%3Dihub.

5. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail [Internet] 2010[citado 16 Abr 2017]; 12:767–78. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1093/eurjhf/hfq120.

6. Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol [Internet]. 2010 Oct 5 [citado 03 May 2017]; 56(15):1247-53. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109710027245?via%3Dihub.

7. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation [Internet]. 2010 May 25 [citado 03 May 2017]; 121(20):2169-75. Disponible en: http://circ.ahajournals.org/content/121/20/2169.long.

8. Méndez Ramírez E. Miocardiopatía periparto. Rev Méd Costa Rica y Centroamérica [Internet]. 2013 [citado 11 Sep 2017]; LXX (607):449-55. Disponible en: http://www.medigraphic.com/pdfs/revmedcoscen/rmc-2013/rmc133m.pdf.

9. Ortega Bravo M, Barco López MA, Calvo Godoy MC, Vila Jove N. Cuadro de insuficiencia cardiaca en mujer joven: miocardiopatía posparto. Semergen [Internet]. 2011 [citado 11 Sep 2017]; 37(7): 372-4. Disponible en: http://www.elsevier.es/es-revista-medicina-familia-semergen-40-articulo-cuadro-insuficiencia-cardiaca-mujer-joven-S1138359311001675.

10. Reyes Ochoa OC, Erazo Acosta NM. Miocardiopatía periparto: reporte de un caso y revisión de literatura. Rev Med Hondur. [Internet]. 2014 [citado 11 Sep 2017]; 82(1):21-4. Disponible en:

http://www.bvs.hn/RMH/pdf/2014/pdf/Vol82-1-2014-6.pdf.

11. Málaga G, Quintana J, Posadas D, Quispe J, Rotta A. Cardiomiopatía periparto temprana complicada con accidente cerebrovascular cardioembólico: A propósito de un caso. Rev Med Hered [Internet]. 2010 [citado 11 Sep 2017]; 21(2):97-102. Disponible en: http://www.upch.edu.pe/vrinve/dugic/revistas/index.php/RMH/article/view/1135/1158.

12. Peradejordi MA, Favaloro LE, Bertolotti A, Absi D, Vigliano C, Laguens R, et al. Predictores de mortalidad o trasplante cardíaco en la miocardiopatía periparto. Rev Argent Cardiol [Internet]. 2013 [citado 12 Sep 2015]; 81(1):45-52. Disponible en: http://www.scielo.org.ar/pdf/rac/v81n1/v81n1a08.pdf.

13. Polanía Ardila DF, Solón Navarrete H, Acuña Osorio EM, Álvarez Rosero RA. Miocardiopatía periparto. Insuf card [Internet]. 2009 [citado 4 Sep 2015]; 4(4):177-83. Disponible en: http://www.scielo.org.ar/pdf/ic/v4n4/v4n4a06.pdf.

14. Bertolotti AM, Peradejordi Lastra MA, Favaloro L, Carballo M, Absi DO, Favaloro LE, et al. Experience with Magnetically-Levitated Centrifugal Flow Pump in Patients with Cardiogenic Shock (INTERMACS 1). Rev Argent Cardiol [Internet]. 2014 [citado 4 de Sep 2015]; 82(3):192-6. Disponible en:http://www.sac.org.ar/wp-content/uploads/2014/06/Experience-with-Magnetically-Levitated-Centrifugal-Flow-Pump-in-Patients-with-Cardiogenic-Shock-INTERMACS-1.pdf.

15. Salinas Botrán A, Ramos Rincón JM, Górgolas Hernández-Mora M. Enfermedad cardiovascular una visión desde la salud global. Med Clin (Barc) [Internet]. 2013 [citado 17 Sep 2015]; 141(5):210-6. Disponible en:

http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90219140&pident_usuario=0&pcontactid=&pident_revista=2&ty=53&accion=L&origen=zonadelectura&web=www.elsevier.es&lan=es&fichero=2v141n05a90219140pdf001.pdf.

16. Chana García M. Miocardiopatía periparto durante una cesárea programada y uso de bromocriptina. Emergencias [Internet]. 2013 [citado 17 Sep 2017]; 25 (2): 160. Disponible en: http://emergencias.portalsemes.org/descargar/miocardiopatia-periparto-durante-una-cesarea-programada-y-uso-de-bromocriptina/.

17. Armijo G, Acuña P, Sarango B, Tamayo C, Donoso H, Sanhueza P, et al. Miocardiopatía periparto. Caso clínico. Rev Chil Cardiol [Internet]. 2014 [citado 19 Sep 2017]; 33(1): 67-73. Disponible en:

https://scielo.conicyt.cl/pdf/rchcardiol/v33n1/art10.pdf.

18. Rendón Garzón R. Cardiomiopatía periparto. Acta Académica [Internet]. 2013 [citado 19 Sep 2017]; 53:193-205. Disponible en:

http://files.bibliotecauaca.com/200000375-9520b97154/016%20-%2053%20CARDIOMIOPAT%C3%8DA%20PERIPARTO%20version%20final%204nov.indd.pdf.

Published

2018-07-05

How to Cite

1.
Vera Pérez JM, Ortíz Hernández L, Piñeiro Mora O. Peripartum cardiomyopathy. Presentation of a case. RM [Internet]. 2018 Jul. 5 [cited 2025 Jun. 15];22(3):628-39. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/893

Issue

Section

CASOS CLÍNICOS